Ulcerative colitis is probably not in fact an autoimmune disease but rather an auto inflammatory disease, although things are complicated.
Further to this, the following thread was tweeted by Dr Gurdasani (clinical epidemiologist and beacon of wisdom in the Covid/Long Covid space). Here she describes her experience of UC.
I don't think this is going off-topic. My question would be: do we think UC is a potential co-morbid disease to ME, with a common predisposition (autoimmune or as Jo clarifies above autoinflammatory); or is UC actually more commonly associated with ME, but ME isn't diagnosed as such, as ME symptoms are put down to the known UC with its clear history and established biomarkers?
Selected quotes from the thread —
The fatigue correlates very well with flare-ups of disease- so it is related to chronic inflammation. When my flare is controlled, the fatigue improves. But it takes months- years to get back to 'normal' after a flare. It's one of the last symptoms to improve.
Sitting on a chair or desk can lead to severe post-exertion malaise (yes, sitting becomes exertion!). Unfortunately, this symptom, while at the heart of my poor quality of life is the one that doctors don't know how to treat, & is generally not the focus of UC research.
The first thing I thought after my exchange with my specialist was that if I was getting recommended psychological therapies for fatigue for what is a well known auto-immune condition - what hope did someone with long COVID/ME/CFS have - where the aetiology is far less clear?
But why don't we focus on lingering symptoms, or symptoms for which we don't know the cause? After all, they massively impact patients. Why don't we research the causes of lingering fatigue in auto-immune/chronic inflammatory disease & look at how we can improve quality of life?
We're learning so much from patients with ME/CFS/Long COVID. Let's not waste these lessons. While I don't think I have ME/CFS/Long COVID, listening to descriptions of PEM helped me understand my own fatigue - of which PEM was a big feature. Much of what I learned about managing it was from the disabled/ME/CFS/Long COVID community, not from my treating team.
We need to transfer this experience to clinicians and researchers. And take this further in patient co-led research to really understand underlying mechanisms, so we can treat them. But first, we need to acknowledge we don't have the answers, believe patients, and really listen.